MedTrace Logo

Hyperosmolality and Acute Kidney Injury After Cardiac Surgery

NCT05914896 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-06-22

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to test if a hyperosmolar prime solution used for cardiopulmonary bypass increases the risk for acute postoperative kidney injury.

Conditions

Interventions

DRUG

HighOsmo

This group received a priming solution with high osmolality

Sponsors & Collaborators

  • Umeå University

    lead OTHER

Principal Investigators

  • Staffan Svenmarker, PhD · Public Health & Clinical Medicine Umeå University, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-24
Primary Completion
2020-06-24
Completion
2020-06-24

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05914896 on ClinicalTrials.gov